
|Articles|August 15, 2004
Incontinence treatments continue to improve, evolve
As treatment approaches to urinary incontinence continue to evolve, their safety and efficacy relative to existing techniques, and in particular the durability of their results, remain important issues for determining their ultimate place in clinical practice.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Optimizing care for men with overactive bladder, with Keith Xavier, MD
4
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
5






